Go Pro
→ Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (From InvestorPlace) (Ad)tc pixel Free ALTO Stock Alerts

Alto Ingredients (ALTO) Financials

Alto Ingredients logo
$4.64 -0.33 (-6.64%)
Closing price 07/24/2026 04:00 PM Eastern
Extended Trading
$4.64 0.00 (0.00%)
As of 07/24/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Alto Ingredients

Annual Income Statements for Alto Ingredients

This table shows Alto Ingredients' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -20 0.15 -36 -62 -90 -16 44 -43 -29 -60 12
Consolidated Net Income / (Loss)		 -19 1.53 -38 -68 -101 -17 46 -42 -28 -59 13
Net Income / (Loss) Continuing Operations		 -19 1.53 -38 -68 -101 -7.32 46 -42 -28 -59 13
Total Pre-Tax Income 		-29 0.55 -38 -68 -101 -17 48 -40 -28 -59 13
Total Operating Income		 -18 24 -26 -52 -75 9.85 40 -61 -24 -52 7.36
Total Gross Profit		 10 54 5.93 -15 -9.94 53 68 -28 16 9.72 35
Total Revenue		 1,191 1,625 1,632 1,515 1,425 897 1,208 1,336 1,223 965 918
Operating Revenue		 1,191 1,625 1,632 1,515 1,425 897 1,208 1,336 1,223 965 918
Total Cost of Revenue		 1,181 1,570 1,626 1,531 1,435 844 1,140 1,363 1,207 956 883
Operating Cost of Revenue		 1,181 1,570 1,626 1,531 1,435 844 1,140 1,363 1,207 956 883
Total Operating Expenses		 28 31 32 36 65 43 28 34 40 61 28
Selling, General & Admin Expense		 26 31 32 36 35 32 29 28 30 30 27
Impairment Charge		 1.97 - - 0.00 29 24 3.10 0.00 6.54 25 0.80
Restructuring Charge		 - - - - - - - 3.50 2.80 7.70 -0.46
Other Special Charges / (Income)		 - - - - 0.00 -13 -4.57 2.23 0.29 -0.83 0.00
Total Other Income / (Expense), net		 -11 -23 -13 -17 -27 -17 7.48 22 -4.06 -7.14 5.36
Interest Expense		 13 22 13 17 27 18 3.59 - 7.43 7.64 11
Other Income / (Expense), net		 1.66 -0.56 0.13 0.17 0.10 0.75 11 24 3.37 0.51 16
Income Tax Expense		 -10 -0.98 -0.32 -0.56 -0.02 -0.02 1.47 1.93 0.10 0.17 -0.62
Preferred Stock Dividends Declared		 1.27 1.27 1.27 1.27 1.27 1.27 1.27 1.27 1.27 1.27 1.27
Basic Earnings per Share		 - $0.00 ($0.85) ($1.42) ($1.90) ($0.28) $0.62 ($0.60) ($0.40) ($0.82) $0.16
Weighted Average Basic Shares Outstanding		 33.17M 42.18K 42.75M 43.38M 47.38M 58.61M 71.10M 71.94M 73.34M 73.48M 74.51M
Diluted Earnings per Share		 ($0.60) $0.00 ($0.85) ($1.42) ($1.90) ($0.28) $0.61 ($0.60) ($0.40) ($0.82) $0.16
Weighted Average Diluted Shares Outstanding		 33.17M 42.25K 42.75M 43.38M 47.38M 58.61M 72.22M 71.94M 73.34M 73.48M 75.66M
Weighted Average Basic & Diluted Shares Outstanding		 33.40M 39.81M 43.96M 43.38M 47.38M 73.17M 73.73M 75.14M 75.70M 76.61M 77.29M

Quarterly Income Statements for Alto Ingredients

This table shows Alto Ingredients' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 -3.81 -19 -12 -3.42 -2.76 -42 -12 -11 14 21 3.96
Consolidated Net Income / (Loss)		 -3.49 -19 -12 -3.11 -2.44 -42 -12 -11 14 22 4.27
Net Income / (Loss) Continuing Operations		 -3.49 -19 -12 -3.11 -2.44 -42 -12 -11 14 22 4.27
Total Pre-Tax Income 		-3.49 -19 -12 -3.11 -2.44 -42 -12 -11 14 21 4.27
Total Operating Income		 -4.33 -17 -10 -1.41 -0.72 -39 -9.00 -8.11 17 7.49 2.52
Total Gross Profit		 4.16 -2.53 -2.40 7.55 5.96 -1.39 -1.81 -1.94 23 15 9.22
Total Revenue		 318 274 241 236 252 236 227 218 241 232 225
Operating Revenue		 318 274 241 236 252 236 227 218 241 232 225
Total Cost of Revenue		 314 276 243 229 246 238 228 220 217 217 215
Operating Cost of Revenue		 314 276 243 229 246 238 228 220 217 217 215
Total Operating Expenses		 8.49 15 7.93 8.96 6.68 38 7.19 6.17 6.51 7.68 6.70
Selling, General & Admin Expense		 8.49 5.58 7.93 8.96 7.51 5.33 7.19 6.17 6.51 7.33 6.70
Total Other Income / (Expense), net		 0.84 -1.68 -1.39 -1.70 -1.72 -2.32 -2.68 -2.89 -2.77 14 1.75
Interest Expense		 - - - 1.67 1.87 - 2.73 2.81 2.80 - -1.70
Other Income / (Expense), net		 2.84 0.45 0.24 -0.03 0.15 0.15 0.05 -0.08 0.03 16 0.05
Income Tax Expense		 0.00 0.10 0.00 0.00 0.00 0.17 0.00 0.00 0.00 -0.62 0.00
Preferred Stock Dividends Declared		 0.32 0.32 0.32 0.32 0.32 0.32 0.31 0.32 0.32 0.32 0.31
Basic Earnings per Share		 ($0.05) - ($0.17) ($0.05) ($0.04) ($0.56) ($0.16) ($0.15) $0.19 $0.28 $0.05
Weighted Average Basic Shares Outstanding		 73.19M 73.34M 72.77M 73.49M 73.84M 73.48M 73.84M 74.61M 74.78M 74.51M 74.79M
Diluted Earnings per Share		 ($0.05) ($0.27) ($0.17) ($0.05) ($0.04) ($0.56) ($0.16) ($0.15) $0.19 $0.28 $0.05
Weighted Average Diluted Shares Outstanding		 73.19M 73.34M 72.77M 73.49M 73.84M 73.48M 73.84M 74.61M 74.78M 75.66M 76.64M
Weighted Average Basic & Diluted Shares Outstanding		 76.14M 75.70M 76.63M 76.49M 76.65M 0.00 - 77.40M 77.34M 0.00 77.49M

Annual Cash Flow Statements for Alto Ingredients

This table details how cash moves in and out of Alto Ingredients' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 -11 13 -15 -23 -15 29 14 -13 -4.05 -9.27 -11
Net Cash From Operating Activities		 -28 37 37 1.57 -31 72 27 6.05 22 -3.52 13
Net Cash From Continuing Operating Activities		 -28 37 37 1.57 -31 72 27 6.05 22 -3.52 13
Net Income / (Loss) Continuing Operations		 -19 1.53 -38 -68 -101 -17 46 -42 -28 -59 13
Consolidated Net Income / (Loss)		 -19 1.53 -38 -68 -101 -17 46 -42 -28 -59 13
Depreciation Expense		 24 35 39 41 48 30 23 25 23 24 25
Amortization Expense		 0.99 2.46 1.14 1.62 1.20 1.16 0.55 0.30 1.85 1.82 1.81
Non-Cash Adjustments To Reconcile Net Income		 3.05 15 8.12 3.13 30 31 -30 -9.31 21 19 -11
Changes in Operating Assets and Liabilities, net		 -37 -17 27 24 -8.72 27 -13 32 3.71 9.96 -16
Net Cash From Investing Activities		 -6.33 -15 -50 -15 -3.28 23 27 -38 -33 -13 -7.43
Net Cash From Continuing Investing Activities		 -6.33 -15 -50 -15 -3.28 23 27 -38 -33 -13 -7.43
Purchase of Property, Plant & Equipment		 -21 -19 -21 -15 -3.28 -6.58 -16 -38 -30 -11 -4.60
Acquisitions		 0.00 0.00 -30 - - 0.00 0.00 -15 0.00 0.00 -7.28
Sale of Property, Plant & Equipment		 - - - - 0.00 0.00 44 15 0.00 0.40 0.00
Other Investing Activities, net		 -4.57 4.57 0.00 - 0.00 30 0.00 0.00 -3.50 -2.80 4.45
Net Cash From Financing Activities		 24 -9.92 -0.84 -9.27 19 -66 -40 19 6.96 7.72 -16
Net Cash From Continuing Financing Activities		 24 -9.92 -0.84 -9.27 19 -76 -40 19 6.96 7.72 -16
Repayment of Debt		 -19 -192 -62 -19 8.25 -112 -38 -5.17 -0.71 0.00 -15
Repurchase of Common Equity		 - - - - - 0.00 0.00 -1.33 -3.67 0.00 0.00
Payment of Dividends		 -1.27 29 -1.27 -1.27 -0.95 0.00 -2.85 -1.27 -1.27 -1.27 -1.27
Cash Interest Paid		 12 11 11 15 19 17 4.12 2.93 10 11 9.05
Cash Income Taxes Paid		 5.71 4.78 5.61 0.74 0.00 -0.64 0.45 -2.26 -0.32 0.63 0.02

Quarterly Cash Flow Statements for Alto Ingredients

This table details how cash moves in and out of Alto Ingredients' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 9.77 11 -3.41 -14 10 -2.28 -9.04 3.32 2.65 -7.47 -4.03
Net Cash From Operating Activities		 23 12 1.43 -14 19 -9.79 -18 -0.85 23 9.54 4.21
Net Cash From Continuing Operating Activities		 23 12 1.43 -14 19 -9.79 -18 -0.85 23 9.54 4.21
Net Income / (Loss) Continuing Operations		 -3.49 -19 -12 -3.11 -2.44 -42 -12 -11 14 22 4.27
Consolidated Net Income / (Loss)		 -3.49 -19 -12 -3.11 -2.44 -42 -12 -11 14 22 4.27
Depreciation Expense		 5.65 5.70 5.73 6.07 6.06 6.55 6.27 6.37 6.26 6.33 6.37
Amortization Expense		 0.50 0.46 0.45 0.45 0.46 0.46 0.45 0.45 0.46 0.46 0.45
Non-Cash Adjustments To Reconcile Net Income		 3.71 21 -1.63 -7.20 2.62 25 0.26 -1.51 -6.75 -2.68 -13
Changes in Operating Assets and Liabilities, net		 17 3.97 8.60 -9.95 12 -0.56 -14 4.84 8.61 -16 6.43
Net Cash From Investing Activities		 -6.64 -4.92 -6.04 -6.05 -0.09 -1.28 -7.81 -2.72 -1.63 4.74 -0.91
Net Cash From Continuing Investing Activities		 -6.64 -4.92 -6.04 -6.05 -0.09 -1.28 -7.81 -2.72 -1.63 4.74 -0.91
Purchase of Property, Plant & Equipment		 -6.64 -4.92 -4.64 -4.65 -0.49 -1.28 -0.53 -0.48 -1.63 -1.95 -0.91
Acquisitions		 - - 0.00 - - - -7.28 - - - 0.00
Net Cash From Financing Activities		 -6.72 3.74 1.21 6.12 -8.39 8.79 17 6.89 -19 -22 -7.33
Net Cash From Continuing Financing Activities		 -6.72 3.74 1.21 6.12 -8.39 8.79 17 6.89 -19 -22 -7.33
Repayment of Debt		 - - - - - - 0.00 - - - -17
Payment of Dividends		 -0.32 -0.32 -0.32 -0.32 -0.32 -0.32 -0.31 -0.32 -0.32 -0.32 -0.31
Issuance of Debt		 -6.40 5.77 1.52 6.44 -8.08 9.10 17 7.21 -18 - 9.58
Cash Interest Paid		 2.67 2.13 2.93 2.88 2.82 2.21 2.23 2.37 2.37 2.08 1.76

Annual Balance Sheets for Alto Ingredients

This table presents Alto Ingredients' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 675 708 720 660 612 477 518 478 454 401 389
Total Current Assets		 198 235 203 169 232 214 230 199 169 153 156
Cash & Equivalents		 53 64 49 27 19 48 51 36 30 35 23
Restricted Cash		 - - - - - 0.52 12 13 15 0.74 2.26
Accounts Receivable		 61 86 80 68 74 43 99 69 59 58 55
Inventories, net		 61 60 62 58 61 38 54 67 53 50 62
Current Deferred & Refundable Income Taxes		 11 5.73 0.74 - - - - - - - 7.50
Other Current Assets		 6.44 8.92 7.84 14 77 84 26 14 12 8.78 6.00
Plant, Property, & Equipment, net		 465 465 508 483 333 229 223 239 249 215 199
Total Noncurrent Assets		 12 7.85 8.70 8.52 48 33 54 40 37 34 34
Intangible Assets		 2.68 2.68 2.68 2.68 2.68 - 2.68 9.09 8.50 4.51 7.57
Other Noncurrent Operating Assets		 9.10 5.17 6.02 5.84 29 33 38 25 28 29 27
Total Liabilities & Shareholders' Equity		 675 708 720 660 612 477 485 478 454 401 389
Total Liabilities		 303 290 337 341 385 181 140 170 175 176 144
Total Current Liabilities		 73 79 91 232 160 87 70 78 65 58 59
Short-Term Debt		 21 11 21 147 66 26 - - - 0.00 17
Accounts Payable		 31 37 40 48 29 13 23 28 21 20 15
Accrued Expenses		 10 20 22 23 22 11 21 27 20 24 17
Other Current Liabilities		 11 10 8.70 14 42 37 31 23 24 13 11
Total Noncurrent Liabilities		 230 211 246 109 225 94 61 92 109 119 84
Long-Term Debt		 204 188 221 85 181 72 50 68 82 93 63
Other Noncurrent Operating Liabilities		 22 23 25 24 44 22 10 24 27 26 21
Total Equity & Noncontrolling Interests		 372 418 384 319 227 296 345 308 280 225 245
Total Preferred & Common Equity		 372 388 356 300 220 296 345 308 280 225 245
Preferred Stock		 - - - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 372 388 356 300 220 296 345 308 280 225 245
Common Stock		 903 923 927 932 942 1,037 1,037 1,041 1,041 1,044 1,052
Retained Earnings		 -532 -532 -568 -630 -720 -737 -692 -735 -764 -824 -812
Accumulated Other Comprehensive Income / (Loss)		 1.04 -2.62 -2.23 -2.46 -2.37 -3.88 -0.28 1.82 2.48 4.98 5.46
Other Equity Adjustments		 - - 0.00 0.00 - - - - - - 0.00

Quarterly Balance Sheets for Alto Ingredients

This table presents Alto Ingredients' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 461 435 432 417 402 393 388 386
Total Current Assets		 168 151 154 145 153 150 151 159
Cash & Equivalents		 26 29 27 34 27 30 33 20
Restricted Cash		 8.70 13 1.29 4.90 0.39 0.72 0.62 1.33
Accounts Receivable		 66 58 64 52 65 57 55 60
Inventories, net		 57 43 49 48 51 54 53 53
Current Deferred & Refundable Income Taxes		 - - - - - - - 12
Other Current Assets		 10 8.08 12 6.60 10 7.91 9.64 13
Plant, Property, & Equipment, net		 249 249 245 239 213 208 204 193
Total Noncurrent Assets		 44 35 34 33 36 35 34 35
Intangible Assets		 8.65 8.35 8.20 8.06 8.14 7.89 7.73 7.42
Other Noncurrent Operating Assets		 29 27 26 25 28 27 26 27
Total Liabilities & Shareholders' Equity		 461 435 432 417 402 393 388 386
Total Liabilities		 163 166 167 153 188 185 166 136
Total Current Liabilities		 58 55 50 45 53 43 42 42
Short-Term Debt		 - - - - - - - 0.00
Accounts Payable		 24 19 20 17 17 16 16 19
Accrued Expenses		 17 18 17 14 24 16 16 12
Other Current Liabilities		 18 18 13 14 12 11 11 10
Total Noncurrent Liabilities		 105 111 117 108 135 143 124 95
Long-Term Debt		 76 84 91 83 111 118 101 73
Other Noncurrent Operating Liabilities		 29 27 26 25 25 24 23 22
Total Equity & Noncontrolling Interests		 298 269 266 264 214 208 222 250
Total Preferred & Common Equity		 298 269 266 264 214 208 222 250
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 298 269 266 264 214 208 222 250
Common Stock		 1,041 1,042 1,043 1,044 1,045 1,050 1,051 1,053
Retained Earnings		 -745 -776 -779 -782 -836 -847 -834 -808
Accumulated Other Comprehensive Income / (Loss)		 1.82 2.48 2.48 2.48 4.98 4.98 4.98 5.46
Other Equity Adjustments		 - - - - - - - 0.00

Annual Metrics And Ratios for Alto Ingredients

This table displays calculated financial ratios and metrics derived from Alto Ingredients' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 38,978,689.00 39,634,084.00 43,971,127.00 45,716,235.00 49,776,465.00 68,494,982.00 72,799,485.00 73,956,108.00 75,911,374.00 75,911,374.00 75,911,374.00
DEI Adjusted Shares Outstanding		 38,978,689.00 39,634,084.00 43,971,127.00 45,716,235.00 49,776,465.00 68,494,982.00 72,799,485.00 73,956,108.00 75,911,374.00 75,911,374.00 75,911,374.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.51 0.00 -0.82 -1.35 -1.81 -0.24 0.61 -0.58 -0.39 -0.79 0.16
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 7.56% 36.40% 0.46% -7.16% -5.97% -37.05% 34.66% 10.57% -8.44% -21.07% -4.90%
EBITDA Growth		 -87.99% 632.53% -76.45% -162.07% -186.28% 265.04% 78.37% -116.60% 135.72% -660.93% 302.54%
EBIT Growth		 -130.81% 240.69% -210.92% -101.78% -45.19% 114.22% 382.30% -174.01% 45.88% -149.80% 145.89%
NOPAT Growth		 -121.78% 623.24% -127.21% -101.43% -44.91% 113.19% 463.02% -210.61% 61.13% -116.68% 121.35%
Net Income Growth		 -172.58% 108.09% -2,595.02% -78.43% -49.08% 82.94% 366.65% -190.27% 32.68% -110.62% 122.61%
EPS Growth		 -169.77% 100.00% 0.00% -67.06% -33.80% 85.26% 317.86% -198.36% 33.33% -105.00% 119.51%
Operating Cash Flow Growth		 -131.69% 232.99% -1.93% -95.71% -2,094.06% 329.55% -62.58% -77.45% 264.11% -115.99% 476.17%
Free Cash Flow Firm Growth		 -697.24% 116.50% -166.67% 139.36% 109.94% 203.07% -86.06% -97.39% -1,730.82% 70.50% -453.86%
Invested Capital Growth		 178.86% 1.05% 4.00% -9.00% -16.29% -21.29% 7.19% -11.70% -3.29% -10.89% 6.19%
Revenue Q/Q Growth		 11.27% 4.16% -2.77% -3.86% 1.66% -17.39% 21.86% -4.10% -4.29% -3.72% -0.48%
EBITDA Q/Q Growth		 -53.35% 45.01% -66.69% -183.18% 54.09% -23.27% 157.89% -138.58% -67.63% -623.71% 522.98%
EBIT Q/Q Growth		 -1,111.06% 320.73% -847.86% -61.82% -11.67% 150.48% 648.51% -602.92% -81.46% -77.52% 159.91%
NOPAT Q/Q Growth		 -273.64% 1,713.27% -769.59% -61.44% -11.51% 180.82% 524.12% -743.83% 36.89% -74.40% 128.04%
Net Income Q/Q Growth		 -276.33% 112.30% -253.19% -42.98% -17.69% 70.51% 2,990.68% -250.60% 33.53% -62.86% 126.58%
EPS Q/Q Growth		 -215.79% 100.00% -254.17% -43.43% -6.74% 65.85% 0.00% 0.00% 0.00% -54.72% 123.53%
Operating Cash Flow Q/Q Growth		 -422.65% 732.10% -36.17% -94.32% 39.62% 0.02% 214.02% -87.44% 52.55% -119.49% 317.67%
Free Cash Flow Firm Q/Q Growth		 -5.84% 1,457.83% -10.76% -45.42% 260.39% -18.64% 164.60% -97.67% 65.00% -118.47% -12.65%
Invested Capital Q/Q Growth		 2.58% 2.12% -0.89% -1.10% -12.89% -7.13% 3.57% -6.19% -6.74% -8.75% 3.22%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 0.87% 3.35% 0.36% -1.00% -0.70% 5.89% 5.61% -2.06% 1.28% 1.01% 3.80%
EBITDA Margin		 0.70% 3.75% 0.88% -0.59% -1.79% 4.69% 6.21% -0.93% 0.36% -2.58% 5.50%
Operating Margin		 -1.51% 1.45% -1.57% -3.40% -5.24% 1.10% 3.32% -4.59% -1.95% -5.35% 0.80%
EBIT Margin		 -1.37% 1.41% -1.56% -3.39% -5.23% 1.18% 4.23% -2.83% -1.67% -5.30% 2.56%
Profit (Net Income) Margin		 -1.58% 0.09% -2.33% -4.48% -7.11% -1.93% 3.82% -3.11% -2.29% -6.11% 1.45%
Tax Burden Percent		 65.29% 280.00% 99.16% 99.18% 99.98% 99.90% 96.91% 104.85% 100.35% 100.29% 104.88%
Interest Burden Percent		 177.20% 2.37% 150.82% 133.35% 135.83% -163.15% 92.99% 104.83% 136.25% 114.94% 54.16%
Effective Tax Rate		 0.00% -180.00% 0.00% 0.00% 0.00% 0.00% 3.09% 0.00% 0.00% 0.00% -4.88%
Return on Invested Capital (ROIC)		 -3.38% 11.95% -3.17% -6.56% -10.86% 1.76% 10.85% -12.32% -5.19% -12.10% 2.66%
ROIC Less NNEP Spread (ROIC-NNEP)		 -11.49% -29.25% -15.47% -22.60% -34.39% -16.78% 30.40% -6.15% -45.99% -60.99% 12.81%
Return on Net Nonoperating Assets (RNNOA)		 -3.02% -11.56% -6.33% -12.77% -26.21% -8.36% 3.52% -0.41% -4.34% -11.28% 3.01%
Return on Equity (ROE)		 -6.40% 0.39% -9.50% -19.33% -37.07% -6.61% 14.37% -12.73% -9.53% -23.38% 5.67%
Cash Return on Invested Capital (CROIC)		 -97.80% 10.90% -7.09% 2.87% 6.87% 25.58% 3.91% 0.10% -1.85% -0.59% -3.35%
Operating Return on Assets (OROA)		 -3.35% 3.32% -3.56% -7.44% -11.72% 1.95% 10.28% -7.60% -4.39% -11.96% 5.94%
Return on Assets (ROA)		 -3.88% 0.22% -5.33% -9.84% -15.92% -3.17% 9.27% -8.35% -6.01% -13.79% 3.38%
Return on Common Equity (ROCE)		 -6.35% 0.37% -8.81% -18.04% -35.25% -6.51% 14.37% -12.73% -9.53% -23.38% 5.67%
Return on Equity Simple (ROE_SIMPLE)		 -5.08% 0.39% -10.68% -22.66% -46.08% -5.83% 13.35% -13.50% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -13 66 -18 -36 -52 6.90 39 -43 -17 -36 7.72
NOPAT Margin		 -1.06% 4.05% -1.10% -2.38% -3.67% 0.77% 3.21% -3.22% -1.37% -3.75% 0.84%
Net Nonoperating Expense Percent (NNEP)		 8.11% 41.19% 12.30% 16.05% 23.53% 18.53% -19.55% -6.18% 40.80% 48.89% -10.15%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - -11.41% -4.62% -11.38% 2.38%
Cost of Revenue to Revenue		 99.13% 96.65% 99.64% 101.00% 100.70% 94.11% 94.39% 102.06% 98.72% 98.99% 96.20%
SG&A Expenses to Revenue		 2.21% 1.90% 1.93% 2.40% 2.49% 3.57% 2.42% 2.10% 2.44% 3.08% 2.96%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 2.38% 1.90% 1.93% 2.40% 4.54% 4.79% 2.29% 2.53% 3.23% 6.36% 3.00%
Earnings before Interest and Taxes (EBIT)		 -16 23 -25 -51 -75 11 51 -38 -20 -51 23
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 8.31 61 14 -8.90 -25 42 75 -12 4.45 -25 51
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.43 0.00 0.55 0.12 0.14 1.07 1.01 0.67 0.70 0.51 0.89
Price to Tangible Book Value (P/TBV)		 0.43 0.00 0.55 0.13 0.14 1.07 1.01 0.71 0.72 0.52 0.92
Price to Revenue (P/Rev)		 0.13 0.00 0.12 0.02 0.02 0.35 0.29 0.16 0.16 0.12 0.24
Price to Earnings (P/E)		 0.00 2.71 0.00 0.00 0.00 0.00 7.86 0.00 0.00 0.00 18.05
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 36.87% 0.00% 0.00% 0.00% 0.00% 12.73% 0.00% 0.00% 0.00% 5.54%
Enterprise Value to Invested Capital (EV/IC)		 0.61 0.30 0.72 0.50 0.61 1.06 0.91 0.69 0.73 0.61 0.91
Enterprise Value to Revenue (EV/Rev)		 0.28 0.10 0.25 0.17 0.19 0.41 0.28 0.17 0.19 0.18 0.30
Enterprise Value to EBITDA (EV/EBITDA)		 40.35 2.73 28.89 0.00 0.00 8.74 4.48 0.00 52.11 0.00 5.38
Enterprise Value to EBIT (EV/EBIT)		 0.00 7.25 0.00 0.00 0.00 34.65 6.56 0.00 0.00 0.00 11.58
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 2.53 0.00 0.00 0.00 53.27 8.64 0.00 0.00 0.00 35.21
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 4.47 11.34 167.15 0.00 5.13 12.51 37.37 10.52 0.00 20.53
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 2.77 0.00 16.60 8.05 3.66 24.00 619.77 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.62 0.48 0.63 0.72 1.09 0.33 0.15 0.22 0.29 0.41 0.32
Long-Term Debt to Equity		 0.56 0.45 0.58 0.27 0.80 0.24 0.15 0.22 0.29 0.41 0.26
Financial Leverage		 0.26 0.40 0.41 0.56 0.76 0.50 0.12 0.07 0.09 0.18 0.24
Leverage Ratio		 1.65 1.75 1.78 1.96 2.33 2.08 1.55 1.52 1.59 1.70 1.68
Compound Leverage Factor		 2.92 0.04 2.69 2.62 3.16 -3.40 1.44 1.60 2.16 1.95 0.91
Debt to Total Capital		 38.16% 32.33% 38.66% 42.02% 52.13% 24.73% 12.73% 18.16% 22.70% 29.22% 24.51%
Short-Term Debt to Total Capital		 3.54% 1.83% 3.29% 26.63% 14.01% 6.49% 0.00% 0.00% 0.00% 0.00% 5.11%
Long-Term Debt to Total Capital		 34.63% 30.51% 35.37% 15.39% 38.12% 18.24% 12.73% 18.16% 22.70% 29.22% 19.40%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 4.91% 4.36% 3.56% 1.53% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 61.83% 62.75% 56.98% 54.42% 46.34% 75.27% 87.27% 81.84% 77.30% 70.78% 75.49%
Debt to EBITDA		 27.60 3.28 16.87 -26.01 -9.71 2.32 0.67 -5.49 18.47 -3.73 1.58
Net Debt to EBITDA		 21.26 2.23 13.42 -23.02 -8.96 1.17 -0.16 -1.51 8.24 -2.27 1.07
Long-Term Debt to EBITDA		 25.04 3.10 15.43 -9.53 -7.10 1.71 0.67 -5.49 18.47 -3.73 1.25
Debt to NOPAT		 -18.23 3.04 -13.50 -6.42 -4.73 14.11 1.30 -1.59 -4.92 -2.57 10.31
Net Debt to NOPAT		 -14.04 2.06 -10.74 -5.68 -4.37 7.13 -0.30 -0.44 -2.19 -1.57 6.99
Long-Term Debt to NOPAT		 -16.54 2.86 -12.35 -2.35 -3.46 10.41 1.30 -1.59 -4.92 -2.57 8.16
Altman Z-Score		 1.12 1.61 1.58 0.65 0.47 1.17 2.65 1.42 1.13 -0.22 0.85
Noncontrolling Interest Sharing Ratio		 0.77% 3.85% 7.19% 6.67% 4.92% 1.39% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.71 2.98 2.24 0.73 1.45 2.46 3.30 2.55 2.59 2.65 2.64
Quick Ratio		 1.56 1.91 1.43 0.41 0.58 1.05 2.14 1.35 1.36 1.62 1.33
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -364 60 -40 16 33 100 14 0.36 -5.95 -1.75 -9.72
Operating Cash Flow to CapEx		 -136.50% 194.19% 174.97% 10.33% -951.75% 1,089.38% 0.00% 26.33% 74.58% -33.01% 288.12%
Free Cash Flow to Firm to Interest Expense		 -28.91 2.68 -3.10 0.92 1.24 5.59 3.90 0.00 -0.80 -0.23 -0.90
Operating Cash Flow to Interest Expense		 -2.22 1.66 2.82 0.09 -1.17 3.99 7.48 0.00 2.97 -0.46 1.23
Operating Cash Flow Less CapEx to Interest Expense		 -3.85 0.81 1.21 -0.79 -1.29 3.63 15.04 0.00 -1.01 -1.86 0.80
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 2.45 2.35 2.29 2.20 2.24 1.65 2.43 2.68 2.62 2.26 2.32
Accounts Receivable Turnover		 24.83 22.01 19.59 20.48 20.08 15.23 17.01 15.98 19.20 16.51 16.21
Inventory Turnover		 29.75 25.98 26.74 25.64 24.23 17.14 24.70 22.53 20.25 18.64 15.83
Fixed Asset Turnover		 3.84 3.49 3.35 3.06 3.50 3.19 5.34 5.79 5.01 4.17 4.44
Accounts Payable Turnover		 54.11 46.48 42.36 34.82 37.05 39.89 62.82 53.08 49.41 46.47 50.63
Days Sales Outstanding (DSO)		 14.70 16.58 18.63 17.82 18.18 23.97 21.46 22.84 19.01 22.11 22.52
Days Inventory Outstanding (DIO)		 12.27 14.05 13.65 14.23 15.06 21.30 14.77 16.20 18.02 19.58 23.06
Days Payable Outstanding (DPO)		 6.75 7.85 8.62 10.48 9.85 9.15 5.81 6.88 7.39 7.85 7.21
Cash Conversion Cycle (CCC)		 20.22 22.78 23.66 21.57 23.39 36.12 30.42 32.17 29.65 33.84 38.38
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 548 554 576 524 439 345 370 327 316 282 299
Invested Capital Turnover		 3.20 2.95 2.89 2.75 2.96 2.29 3.38 3.83 3.80 3.23 3.16
Increase / (Decrease) in Invested Capital		 352 5.74 22 -52 -85 -93 25 -43 -11 -34 17
Enterprise Value (EV)		 335 166 414 262 266 367 336 226 232 171 272
Market Capitalization		 159 0.40 194 37 31 318 347 207 195 115 218
Book Value per Share		 $9.53 $9.79 $8.11 $6.56 $4.42 $4.32 $4.74 $4.17 $3.81 $3.06 $3.29
Tangible Book Value per Share		 $9.46 $9.72 $8.05 $6.50 $4.36 $4.32 $4.71 $3.96 $3.70 $3.00 $3.19
Total Capital		 601 618 626 551 474 394 396 376 362 318 325
Total Debt		 229 200 242 231 247 97 50 68 82 93 80
Total Long-Term Debt		 208 189 221 85 181 72 50 68 82 93 63
Net Debt		 177 136 192 205 228 49 -12 19 37 57 54
Capital Expenditures (CapEx)		 21 19 21 15 3.28 6.58 -27 23 30 11 4.60
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 94 103 84 57 119 104 98 72 58 59 88
Debt-free Net Working Capital (DFNWC)		 146 168 133 84 138 153 160 121 103 95 113
Net Working Capital (NWC)		 125 156 113 -63 72 127 160 121 103 95 97
Net Nonoperating Expense (NNE)		 6.29 64 20 32 49 24 -7.25 -1.35 11 23 -5.62
Net Nonoperating Obligations (NNO)		 177 136 192 205 212 49 25 19 37 57 54
Total Depreciation and Amortization (D&A)		 25 38 40 42 49 31 24 25 25 26 27
Debt-free, Cash-free Net Working Capital to Revenue		 7.86% 6.36% 5.12% 3.76% 8.36% 11.65% 8.10% 5.36% 4.74% 6.12% 9.56%
Debt-free Net Working Capital to Revenue		 12.28% 10.32% 8.16% 5.52% 9.69% 17.02% 13.24% 9.07% 8.46% 9.87% 12.36%
Net Working Capital to Revenue		 10.50% 9.62% 6.89% -4.16% 5.03% 14.17% 13.24% 9.07% 8.46% 9.87% 10.55%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.60) $0.00 $0.00 ($1.42) ($1.90) $0.00 $0.62 ($0.60) ($0.40) ($0.82) $0.16
Adjusted Weighted Average Basic Shares Outstanding		 33.17M 42.18M 42.75M 43.38M 55.89M 73.17M 71.10M 71.94M 73.34M 73.48M 74.51M
Adjusted Diluted Earnings per Share		 ($0.60) $0.00 ($0.85) ($1.42) ($1.90) ($0.28) $0.61 ($0.60) ($0.40) ($0.82) $0.16
Adjusted Weighted Average Diluted Shares Outstanding		 33.17M 42.25M 42.75M 43.38M 55.89M 58.61M 72.22M 71.94M 73.34M 73.48M 75.66M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 ($1.42) ($1.90) $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 38.98M 39.81M 43.96M 48.89M 47.38M 73.17M 73.73M 75.14M 75.70M 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)		 -11 16 -18 -36 -32 15 37 -39 -9.95 -14 5.39
Normalized NOPAT Margin		 -0.94% 1.01% -1.10% -2.38% -2.23% 1.63% 3.10% -2.92% -0.81% -1.45% 0.59%
Pre Tax Income Margin		 -2.43% 0.03% -2.35% -4.52% -7.11% -1.93% 3.94% -2.97% -2.28% -6.09% 1.39%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -1.30 1.02 -1.97 -3.00 -2.79 0.59 14.26 0.00 -2.76 -6.69 2.18
NOPAT to Interest Expense		 -1.00 2.94 -1.38 -2.11 -1.96 0.38 10.83 0.00 -2.25 -4.73 0.72
EBIT Less CapEx to Interest Expense		 -2.92 0.17 -3.58 -3.88 -2.91 0.22 21.82 0.00 -6.74 -8.09 1.75
NOPAT Less CapEx to Interest Expense		 -2.63 2.08 -3.00 -2.99 -2.08 0.02 18.39 0.00 -6.23 -6.13 0.29
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 -6.70% -1,882.77% -3.32% -1.86% -0.93% 0.00% 6.19% -3.04% -4.52% -2.15% 9.48%
Augmented Payout Ratio		 -6.70% -1,882.77% -3.32% -1.86% -0.93% 0.00% 6.19% -6.23% -17.64% -2.15% 9.48%

Quarterly Metrics And Ratios for Alto Ingredients

This table displays calculated financial ratios and metrics derived from Alto Ingredients' official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 75,911,374.00 75,911,374.00 75,911,374.00 75,911,374.00 75,911,374.00 75,911,374.00 75,911,374.00 75,911,374.00 75,911,374.00 75,911,374.00 75,911,374.00
DEI Adjusted Shares Outstanding		 75,911,374.00 75,911,374.00 75,911,374.00 75,911,374.00 75,911,374.00 75,911,374.00 75,911,374.00 75,911,374.00 75,911,374.00 75,911,374.00 75,911,374.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.05 -0.25 -0.16 -0.05 -0.04 -0.55 -0.16 -0.15 0.18 0.28 0.05
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -5.57% -16.69% -23.34% -25.47% -20.84% -13.62% -5.86% -7.63% -4.30% -1.85% -0.82%
EBITDA Growth		 121.72% -725.55% 23.51% -67.09% 27.54% -203.40% 42.80% -126.90% 299.26% 194.80% 519.40%
EBIT Growth		 94.62% -122.16% 13.02% -115.40% 61.45% -133.61% 11.31% -469.66% 3,063.07% 160.44% 128.70%
NOPAT Growth		 84.12% 44.80% 11.08% -110.63% 83.36% -128.38% 12.92% -475.85% 3,469.05% 128.07% 140.01%
Net Income Growth		 87.56% 42.72% 10.94% -140.90% 30.04% -120.17% 0.39% -254.06% 682.06% 152.28% 136.57%
EPS Growth		 0.00% 0.00% 5.56% -150.00% 20.00% -107.41% 5.88% -200.00% 575.00% 150.00% 131.25%
Operating Cash Flow Growth		 222.69% 180.26% 106.12% -231.46% -19.73% -182.99% -1,375.79% 93.82% 22.71% 197.45% 123.09%
Free Cash Flow Firm Growth		 163.87% -105.91% 105.22% 497.81% 362.47% 647.03% -30.85% -4.95% 20.70% -239.68% -119.55%
Invested Capital Growth		 -2.71% -3.29% -5.27% -8.22% -8.92% -10.89% -4.26% -9.96% -6.12% 6.19% 1.30%
Revenue Q/Q Growth		 0.26% -13.99% -12.06% -1.73% 6.49% -6.14% -4.15% -3.58% 10.32% -3.74% -3.14%
EBITDA Q/Q Growth		 -69.88% -326.81% 62.99% 230.15% 16.74% -639.55% 93.02% 38.80% 1,832.94% 28.12% -69.13%
EBIT Q/Q Growth		 -115.96% -1,023.04% 39.65% 85.76% 60.06% -6,705.75% 77.09% 8.54% 307.77% 38.82% -89.12%
NOPAT Q/Q Growth		 -132.67% -296.83% 39.83% 86.37% 48.86% -5,346.53% 77.06% 9.88% 399.18% -54.61% -67.30%
Net Income Q/Q Growth		 -145.94% -442.99% 38.11% 73.51% 21.41% -1,608.81% 72.00% 5.84% 229.20% 53.48% -80.41%
EPS Q/Q Growth		 -150.00% -440.00% 37.04% 70.59% 20.00% -1,300.00% 71.43% 6.25% 226.67% 47.37% -82.14%
Operating Cash Flow Q/Q Growth		 121.52% -49.01% -87.89% -1,060.67% 235.26% -152.73% -86.22% 95.35% 2,786.79% -58.13% -55.88%
Free Cash Flow Firm Q/Q Growth		 189.98% -119.81% 888.54% 183.04% 4.61% -76.57% -0.32% 289.04% 32.84% -127.12% 86.05%
Invested Capital Q/Q Growth		 -5.25% -6.74% -1.75% 5.70% -5.97% -8.75% 5.56% -0.58% -1.97% 3.22% 0.70%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 1.31% -0.92% -1.00% 3.19% 2.37% -0.59% -0.80% -0.89% 9.75% 6.54% 4.10%
EBITDA Margin		 1.46% -3.86% -1.63% 2.15% 2.36% -13.56% -0.99% -0.63% 9.84% 13.10% 4.18%
Operating Margin		 -1.36% -6.28% -4.29% -0.60% -0.29% -16.59% -3.97% -3.71% 7.05% 3.23% 1.12%
EBIT Margin		 -0.47% -6.11% -4.19% -0.61% -0.23% -16.53% -3.95% -3.75% 7.06% 10.18% 1.14%
Profit (Net Income) Margin		 -1.10% -6.92% -4.87% -1.31% -0.97% -17.65% -5.16% -5.03% 5.90% 9.40% 1.90%
Tax Burden Percent		 100.00% 100.51% 100.00% 100.00% 100.00% 100.42% 100.00% 100.00% 100.00% 102.93% 100.00%
Interest Burden Percent		 234.32% 112.71% 116.19% 216.14% 425.26% 106.33% 130.49% 134.34% 83.54% 89.73% 166.25%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -2.93% 0.00%
Return on Invested Capital (ROIC)		 -3.54% -16.71% -10.82% -1.30% -0.62% -37.50% -8.70% -7.77% 21.71% 10.50% 3.43%
ROIC Less NNEP Spread (ROIC-NNEP)		 -5.23% -41.69% -22.61% -4.85% -5.13% -68.07% -17.27% -14.85% 16.78% 35.98% 6.03%
Return on Net Nonoperating Assets (RNNOA)		 -0.45% -3.93% -3.07% -1.02% -0.78% -12.59% -4.49% -4.71% 3.87% 8.47% 1.75%
Return on Equity (ROE)		 -3.99% -20.64% -13.89% -2.32% -1.40% -50.09% -13.19% -12.48% 25.59% 18.96% 5.19%
Cash Return on Invested Capital (CROIC)		 -4.94% -1.85% 0.46% 1.79% 2.93% -0.59% -7.23% -2.32% -2.88% -3.35% 5.15%
Operating Return on Assets (OROA)		 -1.31% -16.03% -10.78% -1.44% -0.52% -37.29% -8.98% -8.47% 16.15% 23.65% 2.66%
Return on Assets (ROA)		 -3.06% -18.16% -12.52% -3.11% -2.21% -39.82% -11.72% -11.38% 13.50% 21.84% 4.42%
Return on Common Equity (ROCE)		 -3.99% -20.64% -13.89% -2.32% -1.40% -50.09% -13.19% -12.48% 25.59% 18.96% 5.19%
Return on Equity Simple (ROE_SIMPLE)		 -14.14% 0.00% -9.89% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -3.03 -12 -7.23 -0.99 -0.50 -27 -6.30 -5.68 17 7.71 2.52
NOPAT Margin		 -0.95% -4.39% -3.01% -0.42% -0.20% -11.61% -2.78% -2.60% 7.05% 3.32% 1.12%
Net Nonoperating Expense Percent (NNEP)		 1.69% 24.98% 11.78% 3.55% 4.51% 30.57% 8.58% 7.08% 4.94% -25.49% -2.60%
Return On Investment Capital (ROIC_SIMPLE)		 - -3.32% -2.05% -0.28% -0.15% -8.63% -1.94% -1.74% 5.26% 2.37% 0.78%
Cost of Revenue to Revenue		 98.69% 100.92% 101.00% 96.81% 97.63% 100.59% 100.80% 100.89% 90.25% 93.46% 95.90%
SG&A Expenses to Revenue		 2.67% 2.04% 3.30% 3.79% 2.98% 2.26% 3.17% 2.83% 2.70% 3.16% 2.98%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 2.67% 5.35% 3.30% 3.79% 2.65% 16.00% 3.17% 2.83% 2.70% 3.31% 2.98%
Earnings before Interest and Taxes (EBIT)		 -1.49 -17 -10 -1.44 -0.57 -39 -8.95 -8.19 17 24 2.57
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 4.66 -11 -3.91 5.09 5.94 -32 -2.24 -1.37 24 30 9.38
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.09 0.70 0.59 0.40 0.45 0.51 0.39 0.41 0.36 0.89 1.48
Price to Tangible Book Value (P/TBV)		 1.14 0.72 0.61 0.41 0.46 0.52 0.41 0.43 0.38 0.92 1.53
Price to Revenue (P/Rev)		 0.25 0.16 0.14 0.10 0.12 0.12 0.09 0.09 0.09 0.24 0.40
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 18.05 13.24
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 5.54% 7.55%
Enterprise Value to Invested Capital (EV/IC)		 1.08 0.73 0.65 0.51 0.53 0.61 0.56 0.59 0.51 0.91 1.40
Enterprise Value to Revenue (EV/Rev)		 0.29 0.19 0.17 0.16 0.16 0.18 0.18 0.19 0.16 0.30 0.46
Enterprise Value to EBITDA (EV/EBITDA)		 26.54 52.11 35.52 0.00 0.00 0.00 0.00 0.00 0.00 5.38 6.80
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 11.58 12.07
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 35.21 21.90
Enterprise Value to Operating Cash Flow (EV/OCF)		 25.25 10.52 4.29 7.46 9.06 0.00 0.00 0.00 0.00 20.53 11.84
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 135.19 27.45 17.24 0.00 0.00 0.00 0.00 0.00 27.41
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.25 0.29 0.31 0.34 0.32 0.41 0.52 0.57 0.45 0.32 0.29
Long-Term Debt to Equity		 0.25 0.29 0.31 0.34 0.32 0.41 0.52 0.57 0.45 0.26 0.29
Financial Leverage		 0.09 0.09 0.14 0.21 0.15 0.18 0.26 0.32 0.23 0.24 0.29
Leverage Ratio		 1.45 1.59 1.59 1.60 1.56 1.70 1.73 1.74 1.66 1.68 1.70
Compound Leverage Factor		 3.39 1.79 1.85 3.45 6.65 1.80 2.26 2.34 1.38 1.51 2.83
Debt to Total Capital		 20.30% 22.70% 23.83% 25.49% 24.00% 29.22% 34.09% 36.28% 31.14% 24.51% 22.62%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 5.11% 0.00%
Long-Term Debt to Total Capital		 20.30% 22.70% 23.83% 25.49% 24.00% 29.22% 34.09% 36.28% 31.14% 19.40% 22.62%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 79.70% 77.30% 76.17% 74.51% 76.00% 70.78% 65.91% 63.72% 68.85% 75.49% 77.38%
Debt to EBITDA		 5.53 18.47 14.88 -19.23 -24.19 -3.73 -4.76 -3.98 -8.42 1.58 1.18
Net Debt to EBITDA		 2.99 8.24 7.44 -13.23 -13.01 -2.27 -3.59 -2.95 -5.65 1.07 0.83
Long-Term Debt to EBITDA		 5.53 18.47 14.88 -19.23 -24.19 -3.73 -4.76 -3.98 -8.42 1.25 1.18
Debt to NOPAT		 -2.87 -4.92 -5.32 -3.91 -4.02 -2.57 -3.14 -2.96 -3.65 10.31 3.79
Net Debt to NOPAT		 -1.55 -2.19 -2.66 -2.69 -2.16 -1.57 -2.37 -2.20 -2.45 6.99 2.67
Long-Term Debt to NOPAT		 -2.87 -4.92 -5.32 -3.91 -4.02 -2.57 -3.14 -2.96 -3.65 8.16 3.79
Altman Z-Score		 1.98 1.16 0.91 0.61 0.53 -0.12 -0.05 -0.11 0.14 0.85 1.46
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.88 2.59 2.74 3.09 3.22 2.65 2.89 3.52 3.56 2.64 3.81
Quick Ratio		 1.58 1.36 1.59 1.83 1.90 1.62 1.74 2.05 2.06 1.33 1.92
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 6.43 -1.27 10 28 30 6.97 6.95 27 36 -9.73 -1.36
Operating Cash Flow to CapEx		 348.23% 239.76% 30.78% -294.97% 3,781.67% -766.04% -3,426.88% -175.21% 1,395.22% 489.73% 463.04%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 17.03 15.93 0.00 2.54 9.61 12.82 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 -8.23 9.95 0.00 -6.68 -0.30 8.14 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 -11.01 9.68 0.00 -6.88 -0.47 7.55 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 2.79 2.62 2.57 2.37 2.28 2.26 2.27 2.26 2.29 2.32 2.32
Accounts Receivable Turnover		 0.00 19.20 18.45 16.77 16.98 16.51 15.40 15.36 17.27 16.21 14.64
Inventory Turnover		 21.68 20.25 20.65 17.62 18.91 18.64 20.19 18.05 17.83 15.83 16.82
Fixed Asset Turnover		 5.30 5.01 4.66 4.35 4.11 4.17 4.12 4.12 4.17 4.44 4.51
Accounts Payable Turnover		 61.76 49.41 52.82 46.11 48.26 46.47 52.95 52.03 55.24 50.63 47.90
Days Sales Outstanding (DSO)		 0.00 19.01 19.78 21.76 21.50 22.11 23.70 23.77 21.13 22.52 24.93
Days Inventory Outstanding (DIO)		 16.84 18.02 17.68 20.71 19.30 19.58 18.08 20.22 20.47 23.06 21.70
Days Payable Outstanding (DPO)		 5.91 7.39 6.91 7.92 7.56 7.85 6.89 7.02 6.61 7.21 7.62
Cash Conversion Cycle (CCC)		 10.93 29.65 30.55 34.56 33.23 33.84 34.89 36.98 35.00 38.38 39.01
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 339 316 311 328 309 282 297 296 290 299 301
Invested Capital Turnover		 3.72 3.80 3.60 3.12 3.10 3.23 3.13 2.99 3.08 3.16 3.06
Increase / (Decrease) in Invested Capital		 -9.46 -11 -17 -29 -30 -34 -13 -33 -19 17 3.88
Enterprise Value (EV)		 365 232 201 169 164 171 168 174 148 272 422
Market Capitalization		 324 195 159 106 119 115 84 86 81 218 371
Book Value per Share		 $3.93 $3.81 $3.69 $3.62 $3.57 $3.06 $2.90 $2.79 $2.97 $3.29 $3.34
Tangible Book Value per Share		 $3.73 $3.70 $3.58 $3.51 $3.47 $3.00 $2.79 $2.68 $2.87 $3.19 $3.24
Total Capital		 374 362 353 357 347 318 325 326 323 325 323
Total Debt		 76 82 84 91 83 93 111 118 101 80 73
Total Long-Term Debt		 76 82 84 91 83 93 111 118 101 63 73
Net Debt		 41 37 42 63 45 57 83 88 67 54 51
Capital Expenditures (CapEx)		 6.64 4.92 4.64 4.65 0.49 1.28 0.53 0.48 1.63 1.95 0.91
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 75 58 54 75 62 59 73 77 75 88 95
Debt-free Net Working Capital (DFNWC)		 110 103 96 104 100 95 100 107 109 113 117
Net Working Capital (NWC)		 110 103 96 104 100 95 100 107 109 97 117
Net Nonoperating Expense (NNE)		 0.46 6.93 4.49 2.12 1.94 14 5.38 5.32 2.77 -14 -1.75
Net Nonoperating Obligations (NNO)		 41 37 42 63 45 57 83 88 67 54 51
Total Depreciation and Amortization (D&A)		 6.15 6.16 6.18 6.53 6.52 7.01 6.71 6.82 6.72 6.78 6.81
Debt-free, Cash-free Net Working Capital to Revenue		 5.86% 4.74% 4.67% 7.06% 6.14% 6.12% 7.69% 8.22% 8.17% 9.56% 10.40%
Debt-free Net Working Capital to Revenue		 8.59% 8.46% 8.33% 9.72% 9.98% 9.87% 10.55% 11.49% 11.76% 12.36% 12.76%
Net Working Capital to Revenue		 8.59% 8.46% 8.33% 9.72% 9.98% 9.87% 10.55% 11.49% 11.76% 10.55% 12.76%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.05) $0.00 $0.00 ($0.05) ($0.04) ($0.56) ($0.16) ($0.15) $0.19 $0.28 $0.05
Adjusted Weighted Average Basic Shares Outstanding		 73.19M 73.34M 72.77M 73.49M 73.84M 73.48M 73.84M 74.61M 74.78M 74.51M 74.79M
Adjusted Diluted Earnings per Share		 $0.00 ($0.27) ($0.17) ($0.05) ($0.04) ($0.56) ($0.16) ($0.15) $0.19 $0.28 $0.05
Adjusted Weighted Average Diluted Shares Outstanding		 76.14M 73.34M 76.63M 73.49M 73.84M 73.48M 73.84M 74.61M 74.78M 75.66M 76.64M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 76.14M 75.70M 76.63M 76.49M 0.00 0.00 0.00 0.00 0.00 0.00 77.49M
Normalized Net Operating Profit after Tax (NOPAT)		 -3.03 -7.84 -7.23 -0.99 -1.09 -27 -6.30 -5.68 12 5.24 1.76
Normalized NOPAT Margin		 -0.95% -2.87% -3.01% -0.42% -0.43% -11.61% -2.78% -2.60% 4.93% 2.26% 0.79%
Pre Tax Income Margin		 -1.10% -6.89% -4.87% -1.31% -0.97% -17.58% -5.16% -5.03% 5.90% 9.13% 1.90%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 -0.86 -0.31 0.00 -3.28 -2.91 6.07 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 -0.59 -0.27 0.00 -2.31 -2.02 6.06 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 -3.65 -0.57 0.00 -3.47 -3.08 5.49 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 -3.38 -0.53 0.00 -2.50 -2.19 5.48 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 -3.00% -4.52% -4.77% -3.41% -3.50% -2.15% -2.15% -1.89% -2.52% 9.48% 4.32%
Augmented Payout Ratio		 -10.14% -17.64% -4.77% -3.41% -3.50% -2.15% -2.15% -1.89% -2.52% 9.48% 4.32%

Financials Breakdown Chart

Key Financial Trends

Alto Ingredients’ first quarter of 2026 showed a meaningful rebound in profitability and operating cash flow compared with the weak quarters seen in 2024 and early 2025. Revenue was down modestly year over year, but the company swung back to positive operating income and net income, helped by much better pricing/margin mix, a lighter cost structure, and lower operating leverage pressure. The balance sheet also improved sequentially, with debt down from year-end 2025 and cash still at a healthy level.

  • Profitability improved sharply in Q1 2026. Alto posted $9.2 million of gross profit, $2.5 million of operating income, and $4.3 million of pre-tax income, a major turnaround from the losses in Q1 2025.
  • Net income turned positive again. Consolidated net income was $4.3 million, or $0.05 per diluted share, versus a loss of $11.7 million in the year-ago quarter.
  • Operating cash flow stayed positive. The company generated $4.2 million of cash from operations, showing that earnings improvement is translating into cash generation.
  • Interest cost pressure eased versus earlier periods. Interest expense was $1.7 million in Q1 2026, lower than the heavy drag seen in several prior quarters.
  • Debt came down sequentially. Long-term debt fell to $73.1 million at March 31, 2026 from $100.6 million at the end of Q3 2025.
  • Revenue held near recent levels. Q1 2026 revenue of $224.7 million was close to the prior quarter and above the depressed levels seen in parts of 2024.
  • Cost of revenue still consumed most sales. Gross margin remained thin, with cost of revenue at $215.5 million against revenue of $224.7 million.
  • Capex remained modest. Purchases of property, plant and equipment were just $0.9 million in Q1 2026, suggesting restrained investment spending.
  • Revenue declined year over year. Q1 2026 sales fell from $226.5 million in Q1 2025, indicating the top line has not fully recovered.
  • Cash declined during the quarter. Cash and equivalents fell to $20.3 million from $32.5 million at the end of Q3 2025, and the company reported a $4.0 million net cash outflow for the quarter.

Looking at the broader trend, Alto has improved materially from 2024’s losses and volatility. In 2024, the company frequently posted negative gross profit and sizable net losses, including a very weak Q4 2024. Through 2025, results became more erratic but improved in the second half of the year, and Q1 2026 continued that recovery with a return to positive operating and bottom-line results.

From a balance sheet perspective, the company still carries meaningful leverage. Total liabilities were $136.4 million at the end of Q1 2026 versus $249.9 million of equity, so equity remains ahead of liabilities. That said, Alto still has a substantial debt load and interest expense remains an important factor for investors to watch.

Bottom line: Alto Ingredients is showing signs of operational recovery, with better margins, positive earnings, and positive operating cash flow in Q1 2026. The main question for investors is whether the company can sustain this improvement while continuing to reduce debt and protect liquidity.

07/25/26 03:11 PM ETAI Generated. May Contain Errors.

Alto Ingredients Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Alto Ingredients' fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Alto Ingredients' net income appears to be on a downward trend, with a most recent value of $13.34 million in 2025, falling from -$18.87 million in 2015. The previous period was -$58.98 million in 2024. Check out Alto Ingredients' forecast to explore projected trends and price targets.

Alto Ingredients' total operating income in 2025 was $7.36 million, based on the following breakdown:
  • Total Gross Profit: $34.91 million
  • Total Operating Expenses: $27.55 million

Over the last 10 years, Alto Ingredients' total revenue changed from $1.19 billion in 2015 to $917.93 million in 2025, a change of -22.9%.

Alto Ingredients' total liabilities were at $143.55 million at the end of 2025, a 18.6% decrease from 2024, and a 52.6% decrease since 2015.

In the past 10 years, Alto Ingredients' cash and equivalents has ranged from $19.00 million in 2019 to $64.26 million in 2016, and is currently $23.42 million as of their latest financial filing in 2025.

Over the last 10 years, Alto Ingredients' book value per share changed from 9.53 in 2015 to 3.29 in 2025, a change of -65.5%.


Related Companies

Financial statements for NASDAQ:ALTO last updated on 7/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
Three oil giants buried the same discovery for 50 years
In 1976, Chevron tapped an energy source with no fuel costs, no carbon, and no supply chain - then killed the ...
Behind the Markets | Sponsoredtc pixel
Elon's new "super startup"
Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...
Banyan Hill Publishing | Sponsoredtc pixel
Where to Put $100 Before Trump's New Tech Law Rolls Out
The Financial Times says a new tech law puts America 'on the verge of a financial revolution.' Yahoo Finance e...
Brownstone Research | Sponsoredtc pixel